96 related articles for article (PubMed ID: 8673564)
21. Platelet adhesion and aggregate formation in type I diabetes under flow conditions.
Nievelstein PF; Sixma JJ; Ottenhof-Rovers M; Wynne HJ; De Groot PG; Banga JD
Diabetes; 1991 Nov; 40(11):1410-7. PubMed ID: 1936602
[TBL] [Abstract][Full Text] [Related]
22. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism.
Merten M; Pakala R; Thiagarajan P; Benedict CR
Circulation; 1999 May; 99(19):2577-82. PubMed ID: 10330391
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of platelet glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa.
Mazurov AV; Khaspekova SG; Byzova TV; Tikhomirov OYu ; Berndt MC; Steiner B; Kouns WC
FEBS Lett; 1996 Aug; 391(1-2):84-8. PubMed ID: 8706936
[TBL] [Abstract][Full Text] [Related]
24. Fibronectin in artery subendothelium is important for platelet adhesion.
Houdijk WP; Sixma JJ
Blood; 1985 Mar; 65(3):598-604. PubMed ID: 3882170
[TBL] [Abstract][Full Text] [Related]
25. Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians.
Curtis BR; Aster RH
Transfusion; 1996 Apr; 36(4):331-4. PubMed ID: 8623134
[TBL] [Abstract][Full Text] [Related]
26. Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.
Lawrence JB; Kramer WS; McKeown LP; Williams SB; Gralnick HR
J Clin Invest; 1990 Nov; 86(5):1715-22. PubMed ID: 2243140
[TBL] [Abstract][Full Text] [Related]
27. Platelet membrane glycoprotein IV (CD36) is involved in arachidonic acid induced-platelet aggregation.
Dutta-Roy AK; Crosbie LC; Gordon MJ; Campbell FM
Biochem Soc Trans; 1996 May; 24(2):167S. PubMed ID: 8736825
[No Abstract] [Full Text] [Related]
28. Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces.
Bastida E; Escolar G; Ordinas A; Sixma JJ
Blood; 1987 Nov; 70(5):1437-42. PubMed ID: 3663940
[TBL] [Abstract][Full Text] [Related]
29. Normal aggregations of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donors.
Yamamoto N; Akamatsu N; Yamazaki H; Tanoue K
Br J Haematol; 1992 May; 81(1):86-92. PubMed ID: 1381610
[TBL] [Abstract][Full Text] [Related]
30. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components.
Sakariassen KS; Aarts PA; de Groot PG; Houdijk WP; Sixma JJ
J Lab Clin Med; 1983 Oct; 102(4):522-35. PubMed ID: 6619647
[TBL] [Abstract][Full Text] [Related]
31. Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen.
de Groot PG; Ottenhof-Rovers M; van Mourik JA; Sixma JJ
J Clin Invest; 1988 Jul; 82(1):65-73. PubMed ID: 2839553
[TBL] [Abstract][Full Text] [Related]
32. [Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall].
Meyer D
Nouv Rev Fr Hematol (1978); 1982; 24(3):145-51. PubMed ID: 6752879
[TBL] [Abstract][Full Text] [Related]
33. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM
J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708
[TBL] [Abstract][Full Text] [Related]
34. Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
Tandon NN; Rock G; Jamieson GA
Br J Haematol; 1994 Dec; 88(4):816-25. PubMed ID: 7529543
[TBL] [Abstract][Full Text] [Related]
35. Both increased and decreased platelet adhesion to thermally injured subendothelium is caused by denaturation of von Willebrand factor.
Bos AN; Post MJ; de Groot PG; Sixma JJ; Borst C
Circulation; 1993 Sep; 88(3):1196-204. PubMed ID: 8353881
[TBL] [Abstract][Full Text] [Related]
36. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion.
Kato K; Kanaji T; Russell S; Kunicki TJ; Furihata K; Kanaji S; Marchese P; Reininger A; Ruggeri ZM; Ware J
Blood; 2003 Sep; 102(5):1701-7. PubMed ID: 12738669
[TBL] [Abstract][Full Text] [Related]
37. Primary arrest of circulating platelets on collagen involves phosphorylation of Syk, cortactin and focal adhesion kinase: studies under flow conditions.
Arderiu G; Díaz-Ricart M; Buckley B; Escolar G; Ordinas A
Biochem J; 2002 May; 364(Pt 1):65-71. PubMed ID: 11988077
[TBL] [Abstract][Full Text] [Related]
38. Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.
Agbanyo FR; Sixma JJ; de Groot PG; Languino LR; Plow EF
J Clin Invest; 1993 Jul; 92(1):288-96. PubMed ID: 7686921
[TBL] [Abstract][Full Text] [Related]
39. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion.
Silverstein RL; Asch AS; Nachman RL
J Clin Invest; 1989 Aug; 84(2):546-52. PubMed ID: 2474571
[TBL] [Abstract][Full Text] [Related]
40. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
